Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6137)
All Articles published online
|
May 15, 2004 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cui HH, Chen CL, Wang JD, Yang YJ, Cun Y, Wu JB, Liu YH, Dan HL, Jian YT, Chen XQ. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol 2004; 10(10): 1521-1525 [PMID: 15133865 DOI: 10.3748/wjg.v10.i10.1521] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i10/1521.htm |
| Number | Citing Articles |
| 1 |
Ann E. Slingerland, Zaker Schwabkey, Diana H. Wiesnoski, Robert R. Jenq. Clinical Evidence for the Microbiome in Inflammatory Diseases. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00400
|
| 2 |
Asa Hakansson, Goran Molin. Gut Microbiota and Inflammation. Nutrients 2011; 3(6): 637 doi: 10.3390/nu3060637
|
| 3 |
Probiotics and bowel inflammation. Arbor Clinical Nutrition Updates 2006; 247: 1 doi: 10.1017/S1446545000000610
|
| 4 |
S.K. BÖHM, W. KRUIS. Probiotics. Annals of the New York Academy of Sciences 2006; 1072(1): 339 doi: 10.1196/annals.1326.005
|
| 5 |
Joana Torres, Pierre Ellul, Jost Langhorst, Antonina Mikocka-Walus, Manuel Barreiro-de Acosta, Chamara Basnayake, Nik John Sheng Ding, Daniela Gilardi, Konstantinos Katsanos, Gabriele Moser, Randi Opheim, Carolina Palmela, Gianluca Pellino, Sander Van der Marel, Stephan R Vavricka. European Crohn’s and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2019; 13(6): 673 doi: 10.1093/ecco-jcc/jjz051
|
| 6 |
Jialu Shi, Peng Du, Qinggang Xie, Nana Wang, Huizhen Li, Etareri Evivie Smith, Chun Li, Fei Liu, Guicheng Huo, Bailiang Li. Protective effects of tryptophan-catabolizing Lactobacillus plantarum KLDS 1.0386 against dextran sodium sulfate-induced colitis in mice. Food & Function 2020; 11(12): 10736 doi: 10.1039/D0FO02622K
|
| 7 |
Dirk Haller, Jean-Michel Antoine, Stig Bengmark, Paul Enck, Ger T. Rijkers, Irene Lenoir-Wijnkoop. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel Syndrome1–3. The Journal of Nutrition 2010; 140(3): 690S doi: 10.3945/jn.109.113746
|
| 8 |
Franco Scaldaferri, Viviana Gerardi, Loris Riccardo Lopetuso, Fabio Del Zompo, Francesca Mangiola, Ivo Boškoski, Giovanni Bruno, Valentina Petito, Lucrezia Laterza, Giovanni Cammarota, Eleonora Gaetani, Alessandro Sgambato, Antonio Gasbarrini. Gut Microbial Flora, Prebiotics, and Probiotics in IBD: Their Current Usage and Utility. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/435268
|
| 9 |
A. Zarfeshani, H. Khaza’ai, R. Mohd Ali, Z. Hambali, K. W. J. Wahle, M. S. A. Mutalib. Effect of Lactobacillus casei on the Production of Pro-Inflammatory Markers in Streptozotocin-Induced Diabetic Rats. Probiotics and Antimicrobial Proteins 2011; 3(3-4): 168 doi: 10.1007/s12602-011-9080-9
|
| 10 |
Borja Sánchez, Lorena Ruiz, Miguel Gueimonde, Patricia Ruas-Madiedo, Abelardo Margolles. Adaptation of bifidobacteria to the gastrointestinal tract and functional consequences. Pharmacological Research 2013; 69(1): 127 doi: 10.1016/j.phrs.2012.11.004
|
| 11 |
Sagar Garud, Alphonso Brown, Adam Cheifetz, Emily B. Levitan, Ciaran P. Kelly. Meta-Analysis of the Placebo Response in Ulcerative Colitis. Digestive Diseases and Sciences 2008; 53(4): 875 doi: 10.1007/s10620-007-9954-6
|
| 12 |
Lakhbir Kaur, Morris Gordon, Patricia Anne Baines, Zipporah Iheozor-Ejiofor, Vasiliki Sinopoulou, Anthony K Akobeng. Probiotics for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD005573.pub3
|
| 13 |
Altug Senol, Mehmet Isler, Recep Sutcu, Mete Akin, Ebru Cakir, Betul M Ceyhan, M Cem Kockar. Kefir treatment ameliorates dextran sulfate sodium-induced colitis in rats. World Journal of Gastroenterology 2015; 21(46): 13020-13029 doi: 10.3748/wjg.v21.i46.13020
|
| 14 |
Ronald L. Koretz. Probiotics in Gastroenterology: How Pro Is the Evidence in Adults?. American Journal of Gastroenterology 2018; 113(8): 1125 doi: 10.1038/s41395-018-0138-0
|
| 15 |
Cuilan Huang, Wujuan Hao, Xuyang Wang, Renmin Zhou, Qiong Lin. Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1211271
|
| 16 |
A.M. O'Hara, J. Keohane, F. Shanahan. Functional Dairy Products. 2007; : 90 doi: 10.1533/9781845693107.1.90
|
| 17 |
Mustafa Ugur, Tumay Ozgur, Oguzhan Ozcan, Seckin Akkucuk, Erol Kilic, Onur Koyuncu, Cem Oruc, Aydogan Akin, Ozan Ozturk, Sedat Motor, Ibrahim Yetim, Muhyittin Temiz. Deneysel Kolit Modelinde Centella Asiatika Ekstresinin Etkinliği. SDÜ Tıp Fakültesi Dergisi 2017; doi: 10.17343/sdutfd.265412
|
| 18 |
Khimara Naidoo, Morris Gordon, Andrew O Fagbemi, Adrian G Thomas, Anthony K Akobeng. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2011; doi: 10.1002/14651858.CD007443.pub2
|
| 19 |
Fereshteh Dehghani, Shima Abdollahi, Farzad Shidfar, Cain C. T. Clark, Sepideh Soltani. Probiotics supplementation and brain-derived neurotrophic factor (BDNF): a systematic review and meta-analysis of randomized controlled trials. Nutritional Neuroscience 2023; 26(10): 942 doi: 10.1080/1028415X.2022.2110664
|
| 20 |
Lana M. Agraib, Mohammed I. Yamani, Reema Tayyem, Awni Taleb Abu-Sneineh, Yaser Mohammed Rayyan. Probiotic supplementation induces remission and changes in the immunoglobulins and inflammatory response in active ulcerative colitis patients: A pilot, randomized, double-blind, placebo-controlled study. Clinical Nutrition ESPEN 2022; 51: 83 doi: 10.1016/j.clnesp.2022.08.020
|
| 21 |
Y. Derwa, D. J. Gracie, P. J. Hamlin, A. C. Ford. Systematic review with meta‐analysis: the efficacy of probiotics in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2017; 46(4): 389 doi: 10.1111/apt.14203
|
| 22 |
Harsharn Gill, Jaya Prasad. Bioactive Components of Milk. Advances in Experimental Medicine and Biology 2008; 606: 423 doi: 10.1007/978-0-387-74087-4_17
|
| 23 |
Johannes Stephani, Katarina Radulovic, Jan Hendrik Niess. Gut Microbiota, Probiotics and Inflammatory Bowel Disease. Archivum Immunologiae et Therapiae Experimentalis 2011; 59(3): 161 doi: 10.1007/s00005-011-0122-5
|
| 24 |
Sandra Macfarlane, Helen Steed, George T. Macfarlane. Intestinal bacteria and inflammatory bowel disease. Critical Reviews in Clinical Laboratory Sciences 2009; 46(1): 25 doi: 10.1080/10408360802485792
|
| 25 |
GV Zuccotti, F Meneghin, C Raimondi, D Dilillo, C Agostoni, E Riva, M Giovannini. Probiotics in Clinical Practice: An Overview. Journal of International Medical Research 2008; 36(1_suppl): 1A doi: 10.1177/14732300080360S101
|
| 26 |
Milad Ashrafizadeh, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh, Saeed Samarghandian. Berberine Administration in Treatment of Colitis: A Review. Current Drug Targets 2020; 21(13): 1385 doi: 10.2174/1389450121666200621193758
|
| 27 |
Éricka L. Souza, Samir D. Elian, Laís M. Paula, Cristiana C. Garcia, Angélica T. Vieira, Mauro M. Teixeira, Rosa M. Arantes, Jacques R. Nicoli, Flaviano S. Martins. Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model. Journal of Medical Microbiology 2016; 65(3): 201 doi: 10.1099/jmm.0.000222
|
| 28 |
Yong Jiang, Zhi‐Guang Zhang, Feng‐Xiang Qi, Ying Zhang, Tao Han. Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta‐analysis of randomized controlled trials. Chronic Diseases and Translational Medicine 2016; 2(1): 34 doi: 10.1016/j.cdtm.2016.07.002
|
| 29 |
R. Chibbar, A. Alahmadi, L.A. Dieleman. The Microbiota in Gastrointestinal Pathophysiology. 2017; : 343 doi: 10.1016/B978-0-12-804024-9.00037-9
|
| 30 |
Meng-Tsung Tien, Stephen E. Girardin, Béatrice Regnault, Lionel Le Bourhis, Marie-Agnès Dillies, Jean-Yves Coppée, Raphaëlle Bourdet-Sicard, Philippe J. Sansonetti, Thierry Pédron. Anti-Inflammatory Effect of Lactobacillus casei on Shigella-Infected Human Intestinal Epithelial Cells. The Journal of Immunology 2006; 176(2): 1228 doi: 10.4049/jimmunol.176.2.1228
|
| 31 |
Gabriele Hörmannsperger, Dirk Haller. Molecular crosstalk of probiotic bacteria with the intestinal immune system: Clinical relevance in the context of inflammatory bowel disease. International Journal of Medical Microbiology 2010; 300(1): 63 doi: 10.1016/j.ijmm.2009.08.006
|
| 32 |
J.J. Dibner, J.D. Richards, C.D. Knight. Microbial Imprinting in Gut Development and Health. Journal of Applied Poultry Research 2008; 17(1): 174 doi: 10.3382/japr.2007-00100
|
| 33 |
M. A. ZOCCO, L. ZILERI DAL VERME, F. CREMONINI, A. C. PISCAGLIA, E. C. NISTA, M. CANDELLI, M. NOVI, D. RIGANTE, I. A. CAZZATO, V. OJETTI, A. ARMUZZI, G. GASBARRINI, A. GASBARRINI. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Alimentary Pharmacology & Therapeutics 2006; 23(11): 1567 doi: 10.1111/j.1365-2036.2006.02927.x
|
| 34 |
Saʼad Y. Salim, Johan D. Söderholm. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflammatory Bowel Diseases 2011; 17(1): 362 doi: 10.1002/ibd.21403
|
| 35 |
Yunjing He, Jingrui Zheng, Binbin Ye, Yongzhao Dai, Ke Nie. Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management. Biochemical Pharmacology 2023; 216: 115787 doi: 10.1016/j.bcp.2023.115787
|
| 36 |
Jingyuan Fang, Yunsheng Yang, Weifen Xie. Chinese expert consensus on the application of live combined Bifidobacterium, Lactobacillus, and Enterococcus powder/capsule in digestive system diseases (2021). Journal of Gastroenterology and Hepatology 2023; 38(7): 1089 doi: 10.1111/jgh.16195
|
| 37 |
Rok Orel, Tina Kamhi Trop. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. World Journal of Gastroenterology 2014; 20(33): 11505-11524 doi: 10.3748/wjg.v20.i33.11505
|
| 38 |
Andrew Clegg, Zipporah Iheozor-Ejiofor, Morris Gordon, John K MacDonald, Anthony K Akobeng. Interventions for maintenance of surgically-induced remission in Crohn’s disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013210
|
| 39 |
Lauranne A.A.P. Derikx, Levinus A. Dieleman, Frank Hoentjen. Probiotics and prebiotics in ulcerative colitis. Best Practice & Research Clinical Gastroenterology 2016; 30(1): 55 doi: 10.1016/j.bpg.2016.02.005
|
| 40 |
Lana M. Agraib, Mohammed I. Yamani, Yaser Mohammed Rayyan, Awni Taleb Abu-Sneineh, Tarek A. Tamimi, Reema Fayez Tayyem. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metabolism and Personalized Therapy 2022; 37(1): 7 doi: 10.1515/dmpt-2021-0150
|
| 41 |
CHANG SOO EUN, YONG SEOK KIM, DONG SOO HAN, JOO HYUN CHOI, A REUM LEE, YOON KYUNG PARK. Lactobacillus casei prevents impaired barrier function in intestinal epithelial cells. APMIS 2011; 119(1): 49 doi: 10.1111/j.1600-0463.2010.02691.x
|
| 42 |
Xin Wang, Ying Li, Junjie Hou, Zelan Wang, Yiming Chen, Shuai Su, Xin Xu, Jie Zhang, Weilong Zhong, Bangmao Wang, Yuming Wang. The secreted protein P75 of Lactobacillus rhamnosus GG regulates the SERT expression via EGFR and NF‐κB pathway. Neurogastroenterology & Motility 2022; 34(9) doi: 10.1111/nmo.14437
|
| 43 |
Cristiano Pagnini, Gianfranco Delle Fave, Giorgos Bamias. Probiotics in inflammatory bowel disease: Pathophysiological background and clinical applications. World Journal of Immunology 2013; 3(3): 31-43 doi: 10.5411/wji.v3.i3.31
|
| 44 |
Larissa Sbaglia Celiberto, Raquel Bedani, Elizeu Antonio Rossi, Daniela Cardoso Umbelino Cavallini. Probiotics: The Scientific Evidence in the Context of Inflammatory Bowel Disease. Critical Reviews in Food Science and Nutrition 2015; : 00 doi: 10.1080/10408398.2014.941457
|
| 45 |
Amany A. Abdin, Eman M. Saeid. An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without “olsalazine”. Journal of Crohn's and Colitis 2008; 2(4): 296 doi: 10.1016/j.crohns.2008.04.002
|
| 46 |
Shyamali Saha, Catherine Tomaro-Duchesneau, Maryam Tabrizian, Satya Prakash. Probiotics as oral health biotherapeutics. Expert Opinion on Biological Therapy 2012; 12(9): 1207 doi: 10.1517/14712598.2012.693474
|
| 47 |
Estelle Gaudier, Catherine Michel, Jean-Pierre Segain, Christine Cherbut, Christine Hoebler. The VSL# 3 Probiotic Mixture Modifies Microflora but Does Not Heal Chronic Dextran-Sodium Sulfate–Induced Colitis or Reinforce the Mucus Barrier in Mice. The Journal of Nutrition 2005; 135(12): 2753 doi: 10.1093/jn/135.12.2753
|
| 48 |
John Keohane, Shomik Sibartie, Fergus Shanahan. Probiotics in Inflammatory Bowel Disease. Seminars in Colon and Rectal Surgery 2006; 17(2): 55 doi: 10.1053/j.scrs.2006.06.001
|
| 49 |
Eamonn M. M. Quigley. Probiotics in the management of colonic disorders. Current Gastroenterology Reports 2007; 9(5): 434 doi: 10.1007/s11894-007-0055-7
|
| 50 |
C. M. C. Chapman, G. R. Gibson, I. Rowland. Health benefits of probiotics: are mixtures more effective than single strains?. European Journal of Nutrition 2011; 50(1): 1 doi: 10.1007/s00394-010-0166-z
|
| 51 |
Mohammad Rudiansyah, Saade Abdalkareem Jasim, Bakhadir S. Azizov, Vadim Samusenkov, Walid Kamal Abdelbasset, Ghulam Yasin, Hawraa Jabbar Mohammad, Mohammed Abed Jawad, Trias Mahmudiono, Seyed Reza Hosseini‐Fard, Rasoul Mirzaei, Sajad Karampoor. The emerging microbiome‐based approaches to IBD therapy: From SCFAs to urolithin A. Journal of Digestive Diseases 2022; 23(8-9): 412 doi: 10.1111/1751-2980.13131
|
| 52 |
Katarina Radulovic, Jan Niess. Intestinal Microbiota in Health and Disease. 2014; doi: 10.1201/b16442-2
|
| 53 |
Seong-Eun Park, Sun Jae Kwon, Kwang-Moon Cho, Seung-Ho Seo, Eun-Ju Kim, Tatsuya Unno, So-Hyeon Bok, Dae-Hun Park, Hong-Seok Son. Intervention with kimchi microbial community ameliorates obesity by regulating gut microbiota. Journal of Microbiology 2020; 58(10): 859 doi: 10.1007/s12275-020-0266-2
|
| 54 |
Yanlin Zhou, Fan Zhang, Liqi Mao, Tongfei Feng, Kaijie Wang, Maosheng Xu, Bin Lv, Xi Wang. Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines. European Journal of Nutrition 2023; 62(1): 139 doi: 10.1007/s00394-022-02958-0
|
| 55 |
Srijita Sireswar, Ishita Ghosh, Gargi Dey. First and second generation probiotic therapeutics for Inflammatory Bowel Disease. PharmaNutrition 2019; 9: 100159 doi: 10.1016/j.phanu.2019.100159
|
| 56 |
Roberta E. Rossi, Tara Whyand, Charles D. Murray, Mark I. Hamilton, Dario Conte, Martyn E. Caplin. The role of dietary supplements in inflammatory bowel disease: a systematic review. European Journal of Gastroenterology & Hepatology 2016; 28(12): 1357 doi: 10.1097/MEG.0000000000000728
|
| 57 |
Andrea Verdugo-Meza, Jiayu Ye, Hansika Dadlani, Sanjoy Ghosh, Deanna L. Gibson. Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients 2020; 12(5): 1434 doi: 10.3390/nu12051434
|
| 58 |
A. Kazempour, R. Kazempoor. The effect of Lacticaseibacillus casei on inflammatory cytokine (IL-8) gene expression induced by exposure to Shigella sonnei in Zebrafish (Danio rerio). Arquivo Brasileiro de Medicina Veterinária e Zootecnia 2022; 74(2): 211 doi: 10.1590/1678-4162-12513
|
| 59 |
Francesca Fava, Julie A. Lovegrove, Kieran M. Tuohy, Glenn R. Gibson. The potential role of the intestinal gut microbiota in obesity and the metabolic syndrome. Food Science & Technology Bulletin: Functional Foods 2009; 5(7): 71 doi: 10.1616/1476-2137.15557
|
| 60 |
Jalal Moludi, Hossein Samadi Kafil, Shaimaa A. Qaisar, Pourya Gholizadeh, Mohammad Alizadeh, Hamed Jafari Vayghyan. Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial. Nutrition Journal 2021; 20(1) doi: 10.1186/s12937-021-00703-7
|
| 61 |
Jongwook Yu, Jae Hee Cheon. Microbial Modulation in Inflammatory Bowel Diseases. Immune Network 2022; 22(6) doi: 10.4110/in.2022.22.e44
|
| 62 |
Mardem Machado de Souza, José Eduardo de Aguilar-Nascimento, Maria Helena Gomes-da-Silva, Rubens Carlos Junior. Effects of budesonide and probiotics enemas on the colonic mucosa of rats with experimental colitis. Acta Cirurgica Brasileira 2007; 22(1): 34 doi: 10.1590/S0102-86502007000100006
|
| 63 |
Cong Dai, Chang-Qing Zheng, Fan-ji Meng, Zheng Zhou, Li-xuan Sang, Min Jiang. VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis. Molecular and Cellular Biochemistry 2013; 374(1-2): 1 doi: 10.1007/s11010-012-1488-3
|
| 64 |
Richard N. Fedorak, Levinus A. Dieleman, Karen L. Madsen. Inflammatory Bowel Disease. 2011; : 123 doi: 10.1007/978-1-60327-433-3_9
|
| 65 |
Frank I. Scott, Faten N. Aberra. Medical Therapy of Ulcerative Colitis. 2014; : 209 doi: 10.1007/978-1-4939-1677-1_18
|
| 66 |
Miranda C. E. Lomer, Bridgette Wilson, Catherine L. Wall. British Dietetic Association consensus guidelines on the nutritional assessment and dietary management of patients with inflammatory bowel disease. Journal of Human Nutrition and Dietetics 2023; 36(1): 336 doi: 10.1111/jhn.13054
|
| 67 |
Hongjing Yu, Lu Liu, Zhen Chang, Shasha Wang, Bin Wen, Peijun Yin, Datao Liu, Bei Chen, Jundong Zhang. Genome Sequence of the Bacterium Bifidobacterium longum Strain CMCC P0001, a Probiotic Strain Used for Treating Gastrointestinal Disease. Genome Announcements 2013; 1(5) doi: 10.1128/genomeA.00716-13
|
| 68 |
Jürgen Stein, Axel Dignaß. Prävention und Therapie von entzündlichen Magen‐/Darm‐Erkrankungen. Pharmazie in unserer Zeit 2012; 41(2): 123 doi: 10.1002/pauz.201100460
|
| 69 |
Therese M Chapman, Greg L Plosker, David P Figgitt. VSL#3 Probiotic Mixture. Drugs 2006; 66(10): 1371 doi: 10.2165/00003495-200666100-00006
|
| 70 |
Peter T Mallon, Damian McKay, Steven J Kirk, Keith Gardiner, Keith Gardiner. Cochrane Database of Systematic Reviews. 2007; doi: 10.1002/14651858.CD005573.pub2
|
| 71 |
P. C. Calder, R. Albers, J.-M. Antoine, S. Blum, R. Bourdet-Sicard, G. A. Ferns, G. Folkerts, P. S. Friedmann, G. S. Frost, F. Guarner, M. Løvik, S. Macfarlane, P. D. Meyer, L. M'Rabet, M. Serafini, W. van Eden, J. van Loo, W. Vas Dias, S. Vidry, B. M. Winklhofer-Roob, J. Zhao. Inflammatory Disease Processes and Interactions with Nutrition. British Journal of Nutrition 2009; 101(S1): 1 doi: 10.1017/S0007114509377867
|
| 72 |
Andrzej Wasilewski, Marta Zielińska, Martin Storr, Jakub Fichna. Beneficial Effects of Probiotics, Prebiotics, Synbiotics, and Psychobiotics in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(7): 1674 doi: 10.1097/MIB.0000000000000364
|
| 73 |
Vincenzo Davide Palumbo, Marcello Romeo, Antonella Marino Gammazza, Francesco Carini, Provvidenza Damiani, Giuseppe Damiano, Salvatore Buscemi, Attilio Ignazio Lo Monte, Alice Gerges-Geagea, Abdo Jurjus, Giovanni Tomasello. The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study. Biomedical Papers 2016; 160(3): 372 doi: 10.5507/bp.2016.044
|
| 74 |
Charlotte Hedin, Kevin Whelan, James O. Lindsay. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proceedings of the Nutrition Society 2007; 66(3): 307 doi: 10.1017/S0029665107005563
|
| 75 |
Cary Qualia, Athos Bousvaros. Probiotic for new onset ulcerative colitis in children: Babyʼs got bac(teria). Inflammatory Bowel Diseases 2010; 16(1): 177 doi: 10.1002/ibd.21062
|
| 76 |
Mattia Pia Arena, Pasquale Russo, Vittorio Capozzi, Ana Rascón, Giovanna E. Felis, Giuseppe Spano, Daniela Fiocco. Combinations of cereal β-glucans and probiotics can enhance the anti-inflammatory activity on host cells by a synergistic effect. Journal of Functional Foods 2016; 23: 12 doi: 10.1016/j.jff.2016.02.015
|
| 77 |
Danielle Barnes, Ann Ming Yeh. Bugs and Guts. Nutrition in Clinical Practice 2015; 30(6): 747 doi: 10.1177/0884533615610081
|
| 78 |
Signe Wildt, Inge Nordgaard, Ulla Hansen, Elke Brockmann, Jüri J. Rumessen. A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis. Journal of Crohn's and Colitis 2011; 5(2): 115 doi: 10.1016/j.crohns.2010.11.004
|
| 79 |
Lili Yang, Shijie Tang, Susan S Baker, Ingrid Arijs, Wensheng Liu, Razan Alkhouri, Ping Lan, Robert D Baker, Zhipeng Tang, Guang Ji, Paul Rutgeerts, Severine Vermeire, Ruixin Zhu, Lixin Zhu. Difference in Pathomechanism Between Crohn’s Disease and Ulcerative Colitis Revealed by Colon Transcriptome. Inflammatory Bowel Diseases 2019; 25(4): 722 doi: 10.1093/ibd/izy359
|
| 80 |
Erola Astó, Iago Méndez, Sergi Audivert, Andreu Farran-Codina, Jordi Espadaler. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients 2019; 11(2): 293 doi: 10.3390/nu11020293
|
| 81 |
Marcos Natal Rufino, Airan Lobo da Costa, Eloisa Nascimento Jorge, Viviane Ferreira Paiano, Marjori Leiva Camparoto, Rogéria Keller, Hermann Bremer-Neto. Synbiotics improve clinical indicators of ulcerative colitis: systematic review with meta-analysis. Nutrition Reviews 2022; 80(2): 157 doi: 10.1093/nutrit/nuab017
|
| 82 |
Michel Adamina, Konstantinos Gerasimidis, Rotem Sigall-Boneh, Oded Zmora, Anthony de Buck van Overstraeten, Marjo Campmans-Kuijpers, Pierre Ellul, Konstantinos Katsanos, Paulo Gustavo Kotze, Nurulamin Noor, Judit Schäfli-Thurnherr, Stephan Vavricka, Catherine Wall, Nicolette Wierdsma, Nuha Yassin, Miranda Lomer. Perioperative Dietary Therapy in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2020; 14(4): 431 doi: 10.1093/ecco-jcc/jjz160
|
| 83 |
Larissa Sbaglia Celiberto, Raquel Bedani, Naiara Naiana Dejani, Alexandra Ivo de Medeiros, José Antonio Sampaio Zuanon, Luis Carlos Spolidorio, Maria Angela Tallarico Adorno, Maria Bernadete Amâncio Varesche, Fábio Carrilho Galvão, Sandro Roberto Valentini, Graciela Font de Valdez, Elizeu Antonio Rossi, Daniela Cardoso Umbelino Cavallini, Hauke Smidt. Effect of a probiotic beverage consumption (Enterococcus faecium CRL 183 and Bifidobacterium longum ATCC 15707) in rats with chemically induced colitis. PLOS ONE 2017; 12(4): e0175935 doi: 10.1371/journal.pone.0175935
|
| 84 |
Hui Min Chen, Xiao Wei Liu, Rui Juan Sun, Jing Yuan Fang. A survey on the developmental intestinal microbiota research in China: The history, funding, and frontiers of gut bacteria. Journal of Digestive Diseases 2015; 16(8): 421 doi: 10.1111/1751-2980.12274
|
| 85 |
V. A. Aksenov, E. L. Nikonov. The application of probiotics for the treatment of inflammatory bowel diseases, hepatopathy, and infectious diseases. Dokazatel'naya gastroenterologiya 2017; 6(2): 35 doi: 10.17116/dokgastro20176235-45
|
| 86 |
Monica Profir, Oana Alexandra Roşu, Ruxandra Florentina Ionescu, Luciana Alexandra Pavelescu, Sanda Maria Cretoiu. Antidotes to Toxins and Drugs. 2024; : 279 doi: 10.1016/B978-0-12-824472-2.00011-7
|
| 87 |
Richard Fedorak, Denny Demeria. Probiotic Bacteria in the Prevention and the Treatment of Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2012; 41(4): 821 doi: 10.1016/j.gtc.2012.08.003
|
| 88 |
Daisy Jonkers, John Penders, Ad Masclee, Marieke Pierik. Probiotics in the Management of Inflammatory Bowel Disease. Drugs 2012; 72(6): 803 doi: 10.2165/11632710-000000000-00000
|
| 89 |
Huantian Cui, Yuzi Cai, Li Wang, Beitian Jia, Junchen Li, Shuwu Zhao, Xiaoqian Chu, Jin Lin, Xiaoyu Zhang, Yuhong Bian, Pengwei Zhuang. Berberine Regulates Treg/Th17 Balance to Treat Ulcerative Colitis Through Modulating the Gut Microbiota in the Colon. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00571
|
| 90 |
Asim K. Duttaroy. Evidence-Based Nutrition and Clinical Evidence of Bioactive Foods in Human Health and Disease. 2021; : 311 doi: 10.1016/B978-0-12-822405-2.00031-1
|
| 91 |
Akihiko Oka, R. Balfour Sartor. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases. Digestive Diseases and Sciences 2020; 65(3): 757 doi: 10.1007/s10620-020-06090-z
|
| 92 |
Abbinaya Elangovan, Jessica R. Allegretti, Monika Fischer. Microbiota modulation-based therapy for luminal GI disorders: current applications of probiotics and fecal microbiota transplantation. Expert Opinion on Biological Therapy 2019; 19(12): 1343 doi: 10.1080/14712598.2019.1673725
|
| 93 |
|
| 94 |
Fatemeh Khalaf Shamsabadi, Mohsen Mirzaee, Narges Baharifar, Abolfazl Sheikh, Sara Sheikhi, Nima Aghamohammadi, Forough Chamaie Nejad, Narges Nourani, Vahid Baharifar, Seyed Nouraddin Mousavinasab, Abdolkarim Sheikhi. In Vitro Immunomodulatory Effects of Sugar-Free Sugarcane Molasses and Bifidobacterium animalis subsp. lactis on IFN-γ and TGF-β Secretion in Ulcerative Colitis Patients. Journal of Advanced Immunopharmacology 2024; 4(1) doi: 10.5812/jai-142990
|
| 95 |
Renata D’Incà, Michela Barollo, Marco Scarpa, Alessia Rosaria Grillo, Paola Brun, Maria Grazia Vettorato, Ignazio Castagliuolo, Giacomo Carlo Sturniolo. Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis. Digestive Diseases and Sciences 2011; 56(4): 1178 doi: 10.1007/s10620-010-1384-1
|
| 96 |
Yasushi Yoshimatsu, Akihiro Yamada, Ryuichi Furukawa, Koji Sono, Aisaku Osamura, Kentaro Nakamura, Hiroshi Aoki, Yukiko Tsuda, Nobuo Hosoe, Nobuo Takada, Yasuo Suzuki. Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis. World Journal of Gastroenterology 2015; 21(19): 5985-5994 doi: 10.3748/wjg.v21.i19.5985
|
| 97 |
Mattia Arena, Graziano Caggianiello, Pasquale Russo, Marzia Albenzio, Salvatore Massa, Daniela Fiocco, Vittorio Capozzi, Giuseppe Spano. Functional Starters for Functional Yogurt. Foods 2015; 4(4): 15 doi: 10.3390/foods4010015
|
| 98 |
Yueying Ma, Dandan Yang, Jin Huang, Kunli Liu, Huirong Liu, Huangan Wu, Chunhui Bao. Probiotics for inflammatory bowel disease: Is there sufficient evidence?. Open Life Sciences 2024; 19(1) doi: 10.1515/biol-2022-0821
|
| 99 |
Jean Guy LeBlanc, Alejandra de Moreno de LeBlanc. Probiotics, Prebiotics, and Synbiotics. 2016; : 755 doi: 10.1016/B978-0-12-802189-7.00057-5
|
| 100 |
Zhi Bing Qiu, Jian Chen, Jia Jie Chen, Lan Rong, Wei Qun Ding, Hai Jing Yang, Liang Zhong. Effect of recombinant Lactobacillus casei expressing interleukin‐10 in dextran sulfate sodium‐induced colitis mice. Journal of Digestive Diseases 2013; 14(2): 76 doi: 10.1111/1751-2980.12006
|
| 101 |
Maliha Naseer, Shiva Poola, Syed Ali, Sami Samiullah, Veysel Tahan. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?. Current Clinical Pharmacology 2020; 15(3): 216 doi: 10.2174/1574884715666200312100237
|
| 102 |
John Keohane, Fergus Shanahan. Inflammatory Bowel Disease. 2010; : 392 doi: 10.1002/9781444318418.ch26
|
| 103 |
Kathryn Prame Kumar, Joshua D. Ooi, Rimma Goldberg. The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1291724
|
| 104 |
Y W Chung, J H Choi, T-Y Oh, C S Eun, D S Han.
Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice. Clinical and Experimental Immunology 2007; 151(1): 182 doi: 10.1111/j.1365-2249.2007.03549.x
|
| 105 |
Jonathan D Schepper, Fraser Collins, Naiomy Deliz Rios-Arce, Ho Jun Kang, Laura Schaefer, Joseph D Gardinier, Ruma Raghuvanshi, Robert A Quinn, Robert Britton, Narayanan Parameswaran, Laura R McCabe. Involvement of the Gut Microbiota and Barrier Function in Glucocorticoid-Induced Osteoporosis. Journal of Bone and Mineral Research 2020; 35(4): 801 doi: 10.1002/jbmr.3947
|
| 106 |
Fang WANG, Hai Ying ZHAO, Shu Tian ZHANG, You Zhe GONG, Hai Fang ZHANG, Chuan ZHANG. Effect of enteral nutrition on dextran sulfate sodium‐induced colitis in rats. Journal of Digestive Diseases 2011; 12(6): 453 doi: 10.1111/j.1751-2980.2011.00518.x
|
| 107 |
Satya Prakash, Catherine Tomaro-Duchesneau, Shyamali Saha, Arielle Cantor. The Gut Microbiota and Human Health with an Emphasis on the Use of Microencapsulated Bacterial Cells. Journal of Biomedicine and Biotechnology 2011; 2011: 1 doi: 10.1155/2011/981214
|
| 108 |
Ken Chen, You-Ming Long, Hui Wang, Lei Lan, Zhen-He Lin. Activation of nuclear factor-kappa B and effects of pyrrolidine dithiocarbamate on TNBS-induced rat colitis. World Journal of Gastroenterology 2005; 11(10): 1508-1514 doi: 10.3748/wjg.v11.i10.1508
|
| 109 |
Parvirti Dhillon, Kuljit Singh. Therapeutic applications of probiotics in ulcerative colitis: An updated review. PharmaNutrition 2020; 13: 100194 doi: 10.1016/j.phanu.2020.100194
|
| 110 |
Maria Serena Britti, Marianna Roselli, Alberto Finamore, Nicolò Merendino, Elena Mengheri. Regulation of immune response at intestinal and peripheral sites by probiotics. Biologia 2006; 61(6): 735 doi: 10.2478/s11756-006-0150-5
|
| 111 |
R??my Meier, Michael Steuerwald. Place of probiotics. Current Opinion in Critical Care 2005; 11(4): 318 doi: 10.1097/01.ccx.0000166396.42894.60
|
| 112 |
Xiao-Feng Zhang, Xiao-Xian Guan, Yu-Jun Tang, Jin-Feng Sun, Xiao-Kai Wang, Wei-Dong Wang, Jian-Ming Fan. Clinical effects and gut microbiota changes of using probiotics, prebiotics or synbiotics in inflammatory bowel disease: a systematic review and meta-analysis. European Journal of Nutrition 2021; 60(5): 2855 doi: 10.1007/s00394-021-02503-5
|
| 113 |
Giovanna Vitaliti, Piero Pavone, Francesco Guglielmo, Giuseppina Spataro, Raffaele Falsaperla. The immunomodulatory effect of probiotics beyond atopy: an update. Journal of Asthma 2014; 51(3): 320 doi: 10.3109/02770903.2013.862259
|
| 114 |
Zipporah Iheozor-Ejiofor, Morris Gordon, Andrew Clegg, Suzanne C Freeman, Teuta Gjuladin-Hellon, John K MacDonald, Anthony K Akobeng. Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta-analysis. Cochrane Database of Systematic Reviews 2019; 2019(9) doi: 10.1002/14651858.CD013210.pub2
|
| 115 |
Maram Suresh Gupta, Tegginamath Pramod Kumar, Devegowda Vishkante Gowda, Jessica M. Rosenholm. Orodispersible films: Conception to quality by design. Advanced Drug Delivery Reviews 2021; 178: 113983 doi: 10.1016/j.addr.2021.113983
|
| 116 |
Yukiko Tsuda, Yasushi Yoshimatsu, Hiroshi Aoki, Kentaro Nakamura, Masaki Irie, Katsuyuki Fukuda, Nobuo Hosoe, Nobuo Takada, Koji Shirai, Yasuo Suzuki. Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy. Scandinavian Journal of Gastroenterology 2007; 42(11): 1306 doi: 10.1080/00365520701396091
|
| 117 |
S. Anand, S. Mandal, P. Patil, S. K. Tomar. Pathogen-induced secretory diarrhea and its prevention. European Journal of Clinical Microbiology & Infectious Diseases 2016; 35(11): 1721 doi: 10.1007/s10096-016-2726-5
|
| 118 |
Yingdi Zhang, Xiaojing Zhao, Yunjuan Zhu, Jingjing Ma, Haiqin Ma, Hongjie Zhang. Probiotic Mixture Protects Dextran Sulfate Sodium-Induced Colitis by Altering Tight Junction Protein Expressions and Increasing Tregs. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/9416391
|
| 119 |
E. P. Culligan, C. Hill, R. D. Sleator. Probiotic Bacteria and Enteric Infections. 2011; : 445 doi: 10.1007/978-94-007-0386-5_19
|
| 120 |
Harsharn S. Gill, Sunita Grover, Virender K. Batish, Preet Gill. Prebiotics and Probiotics Science and Technology. 2009; : 901 doi: 10.1007/978-0-387-79058-9_23
|
| 121 |
Michael de Vrese, B. Offick. Bioactive Foods in Promoting Health. 2010; : 205 doi: 10.1016/B978-0-12-374938-3.00014-1
|
| 122 |
Alejandra de Moreno de LeBlanc, Silvina del Carmen, Meritxell Zurita-Turk, Clarissa Santos Rocha, Maarten van de Guchte, Vasco Azevedo, Anderson Miyoshi, Jean Guy LeBlanc. Importance of IL-10 Modulation by Probiotic Microorganisms in Gastrointestinal Inflammatory Diseases. ISRN Gastroenterology 2011; 2011: 1 doi: 10.5402/2011/892971
|
| 123 |
Chao Ding, Xiaolong Ge, Xueying Zhang, Hongliang Tian, Hongkan Wang, Lili Gu, Jianfeng Gong, Weiming Zhu, Ning Li. Efficacy of Synbiotics in Patients with Slow Transit Constipation: A Prospective Randomized Trial. Nutrients 2016; 8(10): 605 doi: 10.3390/nu8100605
|
| 124 |
Eamonn P Culligan, Colin Hill, Roy D Sleator. Probiotics and gastrointestinal disease: successes, problems and future prospects. Gut Pathogens 2009; 1(1) doi: 10.1186/1757-4749-1-19
|
| 125 |
Georgios Vakadaris, Christos Stefanis, Elpida Giorgi, Merkourios Brouvalis, Chrysoula (Chrysa) Voidarou, Yiannis Kourkoutas, Christina Tsigalou, Eugenia Bezirtzoglou. The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature. Biomedicines 2023; 11(2): 494 doi: 10.3390/biomedicines11020494
|
| 126 |
Richa Chibbar, Levinus A. Dieleman. Probiotics in the Management of Ulcerative Colitis. Journal of Clinical Gastroenterology 2015; 49(Supplement 1): S50 doi: 10.1097/MCG.0000000000000368
|
| 127 |
Silvina del Carmen, Alejandra de Moreno de LeBlanc, Anderson Miyoshi, Clarissa Santos Rocha, Vasco Azevedo, Jean Guy LeBlanc. Potential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases. Ulcers 2011; 2011: 1 doi: 10.1155/2011/841651
|
| 128 |
Maria Jose Saez-Lara, Carolina Gomez-Llorente, Julio Plaza-Diaz, Angel Gil. The Role of Probiotic Lactic Acid Bacteria and Bifidobacteria in the Prevention and Treatment of Inflammatory Bowel Disease and Other Related Diseases: A Systematic Review of Randomized Human Clinical Trials. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/505878
|
| 129 |
Lana M. Agraib, Mohammed I. Yamani, Yaser Mohammed Rayyan, Awni Taleb Abu-Sneineh, Tarek A. Tamimi, Reema Fayez Tayyem. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review. Drug Metabolism and Personalized Therapy 2022; 37(1): 7 doi: 10.1515/dmpt-2021-0150
|
| 130 |
Lingfeng Li, Tianyu Liu, Yu Gu, Xinyu Wang, Runxiang Xie, Yue Sun, Bangmao Wang, Hailong Cao. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.974305
|
| 131 |
Larissa S. Celiberto, Franziska A. Graef, Genelle R. Healey, Else S. Bosman, Kevan Jacobson, Laura M. Sly, Bruce A. Vallance. Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome. Immunology 2018; 155(1): 36 doi: 10.1111/imm.12939
|
| 132 |
Mahdi Shadnoush, Rahebeh Shaker Hosseini, Ahad Khalilnezhad, Lida Navai, Hossein Goudarzi, Maryam Vaezjalali. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. The Korean Journal of Gastroenterology 2015; 65(4): 215 doi: 10.4166/kjg.2015.65.4.215
|
| 133 |
Valentina Giacchi, Pietro Sciacca, Pasqua Betta. Probiotics, Prebiotics, and Synbiotics. 2016; : 279 doi: 10.1016/B978-0-12-802189-7.00019-8
|
| 134 |
Li-Wei Feng, Yue Zhao. Efficacy and safety of probiotics in adults with ulcerative colitis: A meta-analysis of placebo-controlled trials. World Chinese Journal of Digestology 2019; 27(6): 367 doi: 10.11569/wcjd.v27.i6.367
|
| 135 |
Andrew O Fagbemi, Adrian G Thomas, Anthony Kwaku Akobeng, Anthony Kwaku Akobeng. Cochrane Database of Systematic Reviews. 2008; doi: 10.1002/14651858.CD007443
|
| 136 |
Faten N Aberra. To be or not to be: Infliximab during pregnancy?. Inflammatory Bowel Diseases 2006; 12(1): 76 doi: 10.1097/01.MIB.0000186489.53493.8a
|
| 137 |
E.S. Klaassens, W.M. de Vos, E.E. Vaughan. Functional Dairy Products. 2007; : 303 doi: 10.1533/9781845693107.3.303
|
| 138 |
Richard R Sharp, Jean-Paul Achkar, Margaret A Brinich, Ruth M Farrell. Helping Patients Make Informed Choices About Probiotics: A Need for Research. The American Journal of Gastroenterology 2009; 104(4): 809 doi: 10.1038/ajg.2008.68
|
| 139 |
Yong-li Hua, Ya-qian Jia, Xiao-song Zhang, Zi-wen Yuan, Peng Ji, Jun-jie Hu, Yan-ming Wei. Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5. Biomedicine & Pharmacotherapy 2021; 137: 111320 doi: 10.1016/j.biopha.2021.111320
|
| 140 |
Matthijs Bekkers, Bojan Stojkovic, Gerard E. Kaiko. Mining the Microbiome and Microbiota-Derived Molecules in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2021; 22(20): 11243 doi: 10.3390/ijms222011243
|
| 141 |
Apurva Jadhav, Suresh Jagtap, Suresh Vyavahare, Archana Sharbidre, Bipinraj Kunchiraman. Reviewing the potential of probiotics, prebiotics and synbiotics: advancements in treatment of ulcerative colitis. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1268041
|
| 142 |
|
| 143 |
Mark T. Osterman, Gary R. Lichtenstein. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; : 1975 doi: 10.1016/B978-1-4160-6189-2.00112-8
|
| 144 |
|
| 145 |
George T. Macfarlane, Sandra Macfarlane. The Human Microbiota. 2013; : 315 doi: 10.1002/9781118409855.ch14
|
| 146 |
G. Zoumpopoulou, E. Tsakalidou, L.V. Thomas. Probiotic Dairy Products. 2017; : 293 doi: 10.1002/9781119214137.ch8
|
| 147 |
Zipporah Iheozor-Ejiofor, Lakhbir Kaur, Morris Gordon, Patricia Anne Baines, Vasiliki Sinopoulou, Anthony K Akobeng. Probiotics for maintenance of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2020; doi: 10.1002/14651858.CD007443.pub3
|
| 148 |
Richard Neil Fedorak, Levinus Albert Dieleman. Probiotics in the Treatment of Human Inflammatory Bowel Diseases. Journal of Clinical Gastroenterology 2008; 42(Supplement 2): S97 doi: 10.1097/MCG.0b013e3181618ac7
|